Schonfeld Strategic Advisors’s Edgewise Therapeutics EWTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.19M | Sell |
167,340
-111,633
| -40% | -$1.46M | 0.01% | 848 |
|
|
2025
Q1 | $6.14M | Buy |
278,973
+10,464
| +4% | +$230K | 0.04% | 414 |
|
|
2024
Q4 | $7.17M | Sell |
268,509
-277,037
| -51% | -$7.4M | 0.04% | 368 |
|
|
2024
Q3 | $14.6M | Buy |
545,546
+467,412
| +598% | +$12.5M | 0.1% | 174 |
|
|
2024
Q2 | $1.41M | Sell |
78,134
-206,466
| -73% | -$3.72M | 0.01% | 938 |
|
|
2024
Q1 | $5.19M | Sell |
284,600
-34,500
| -11% | -$629K | 0.03% | 530 |
|
|
2023
Q4 | $3.49M | Buy |
319,100
+202,200
| +173% | +$2.21M | 0.02% | 562 |
|
|
2023
Q3 | $670K | Buy |
116,900
+3,900
| +3% | +$22.3K | 0.01% | 1015 |
|
|
2023
Q2 | $876K | Buy |
113,000
+100,782
| +825% | +$781K | 0.01% | 1006 |
|
|
2023
Q1 | $81.5K | Buy |
+12,218
| New | +$81.5K | ﹤0.01% | 1675 |
|